Clinical trial
PTQA: A New Paradigm of Transfusion Decision Support for Patients With MDS
NCT03660228 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PTQA: A New Paradigm of Transfusion Decision Support for Patients With MDS
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 17, 2018
- Completion date
- June 30, 2021
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.